MELINDA SCHAITEL: Open Payments
NPI 1912436460 · ONALASKA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 23 payments from 8 companies in 2025. Trend: 2023 $660 · 2024 $582 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 5 | $202 |
| AstraZeneca Pharmaceuticals LP | 11 | $152 |
| HOSPIRA, INC. | 2 | $39 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
| Pharming Healthcare, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: NEFFY, AIRSUPRA, TEZSPIRE, Sajazir, OCTAGAM IMMUNE GLOBULIN (HUMAN), RUCONEST, PANZYGA, DUPIXENT.
Industry payments across WI — which companies pay providers there.
